We narrowed to 714 results for: Mak

...and more photostable than fluorescent proteins, making them ideal for single-molecule fluorescence techniques...

...that they don’t always require needles. If needles make you cringe or your experiment will allow you to ...

...of rAAV production.  Of course, you will want to make sure that your final stocks only contain rAAV. To...

...summaries of recent plasmid deposits and we hope they'll make it easier for you to find and use the plasmids you...

...translated at the ribosome into polypeptide chains that make up the primary structure of proteins. Most proteins...

...if you’d like to use homology directed repair to make precise edits or knock-ins. Editing efficiency decreases...

...interested in viewing which has drawn a large crowd, making it difficult to see the actual poster or interact...

...ability to differentiate into multiple cell types makes them useful models for developmental processes and...

... protein characteristics. For example, Masato Kanemaki's lab has developed a CRISPR/Cas-based system for...

...will ‘look’ similar on your flow plot. This will make it difficult to properly gate your desired cell ...

...target cells (Beatty et al., 2012). These features make AdV an attractive candidate for in vivo delivery...

...is required for NgAgo optimization before we can make any major conclusions: That said, many people are...

...process – such as the viral DNA polymerase – it makes sense that vectorization strategies include creating...

...synaptic transmission, are right around 250 nm, making it difficult to study the inner workings of the...

...decide which ones to use? Here are some tips for making those decisions: Always always always look at ...

...don’t require a PAM sequence at the target locus, making them more flexible than Cas9/Cpf1. Some Cas13 enzymes...

...added log-normal noise to each of the terms which make up our distribution, resulting in the following ...

...number of administrative and practical decisions to make. How often will you hold it? How many people do ...

...started, and 10 more years to obtain FDA approval and make history in the form of Luxturna™. A better vector...

...domain proteins, they can be expressed in bacteria, making nanobodies a recombinant and renewable anti-IgG...